Paul Tudor Jones Vera Therapeutics, Inc. Transaction History
Tudor Investment Corp Et Al
- $29 Billion
- Q1 2025
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 46,063 shares of VERA stock, worth $911,586. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,063
Previous 31,843
44.66%
Holding current value
$911,586
Previous $1.35 Million
17.83%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding VERA
# of Institutions
198Shares Held
63.7MCall Options Held
723KPut Options Held
193K-
Avoro Capital Advisors LLC New York, NY5.7MShares$113 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$94.1 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$66.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3MShares$59.4 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$58.6 Million19.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $535M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...